Literature DB >> 8119150

Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures.

T Shuto1, T Kukita, M Hirata, E Jimi, T Koga.   

Abstract

We investigated the effect of glucocorticoid on the generation of osteoclasts. In mouse bone marrow culture systems, dexamethasone, a synthetic glucocorticoid analog, enhanced osteoclast-like cell formation induced by 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] in a dose-dependent manner. Conversely, dexamethasone inhibited the endogenous production of granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow cultures. GM-CSF, when added exogenously, suppressed not only the osteoclast-like cell formation induced by 1,25-(OH)2D3, but also the stimulatory effect of dexamethasone, and addition of anti-GM-CSF neutralizing antibody to the cultures significantly increased the osteoclast-like cell formation induced by 1,25-(OH)2D3. These observations suggest that dexamethasone directly affects bone marrow cells and enhances osteoclast generation by inhibiting the endogenous production of GM-CSF, which may function as a negative regulator of osteoclast formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119150     DOI: 10.1210/endo.134.3.8119150

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse marrow culture: interaction with dexamethasone.

Authors:  S Kishi; M Yamaguchi
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 4.  Cytokines in the pathogenesis of osteoporosis.

Authors:  E Romas; T J Martin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

Authors:  Y Okada; J A Lorenzo; A M Freeman; M Tomita; S G Morham; L G Raisz; C C Pilbeam
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

6.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice.

Authors:  Hector L Aguila; Se Hwan Mun; Judith Kalinowski; Douglas J Adams; Joseph A Lorenzo; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

8.  Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.

Authors:  Y Y Myint; K Miyakawa; M Naito; L D Shultz; Y Oike; K Yamamura; K Takahashi
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

9.  Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo.

Authors:  Hee Yeon Won; Se Hwan Mun; Bongjin Shin; Sun-Kyeong Lee
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

10.  Sex-specific association of the glucocorticoid receptor gene with extreme BMD.

Authors:  Yu-Mei Peng; Shu-Feng Lei; Yan Guo; Dong-Hai Xiong; Han Yan; Liang Wang; Yan-Fang Guo; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-02       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.